Actively Recruiting
Parascapular Sub Iliocostalis Plane Block Versus Thoracic Paravertebral Plane Block for Traumatic Multiple Rib Fractures
Led by Zagazig University · Updated on 2026-05-13
36
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pain control of rib fractures is essential for not only primary pain relief but also preventing secondary complications such as atelectasis or pneumonia which increase the hospital stay, as well as the transition to chronic pain. The cornerstones of analgesic management are oral and intravenous medications such as paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids as well as regional block techniques as paravertebral block and thoracic epidural. To avoid opioid as well as regional block related side effects such as pneumothorax and hemodynamic instability, previous studies showed that superficial chest wall block such as thoracic erector spinae plane block and serratus anterior plane block had shown a promising success in management of such pain with few side effects. In an effort to reduce the pain score, hospital stay and improve the patient's capability of physiotherapy this study compares continuous block of parascapular sub-iliocostalis plane block versus continuous thoracic paravertebral block for analgesia in patients with traumatic multiple rib fractures.
CONDITIONS
Official Title
Parascapular Sub Iliocostalis Plane Block Versus Thoracic Paravertebral Plane Block for Traumatic Multiple Rib Fractures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient written informed consent.
- ASA physical status I to III.
- Age between 21 and 60 years old.
- Both genders.
- Body mass index less than 35 Kg/M2.
- Patient has accepted mental state.
- Unilateral multiple rib fractures with 2 or more fractured ribs.
You will not qualify if you...
- Any trauma interfering with patient positioning for block.
- Need for mechanical ventilation before or during study.
- Associated head trauma.
- Hemodynamic instability requiring inotropic support.
- Abbreviated injury scale in extremity greater than 2.
- Pathological coagulopathy.
- Infection at the injection site.
- Disturbed consciousness.
- Allergy to local anesthetics or study drugs.
- Pregnancy.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zagazig university
Zagazig, Sharqia Province, Egypt, 44111
Actively Recruiting
Research Team
R
R A Kamel, MD
CONTACT
D
D A Abo El Naga, MSC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here